Kevin E. Lofton
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
MiniMed Set for Medtronic Split-Off, Analysts Set New Targets. Medtronic has finalized the exchange ratio for the MiniMed split-off, a key corporate event for the stock. Meanwhile, Mizuho raised its price target to $28, while Barclays initiated coverage with a lower target of $22. Recent studies also highlighted that responding to MiniMed's diabetes alerts is linked to better glucose outcomes.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Gilead Signs $1.9B Deal With Vir For T-Cell Engagers. Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.
Transaction History
| MDT | ▼ Sell | Tax Withholding | 207 | $17K | 4/28/2026 | View on chart |
| MDT | ▲ Buy | Grant | 2,111 | $0 | 4/27/2026 | View on chart |
| MMED | ▲ Buy | Grant | 27,778 | $0 | 3/9/2026 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 216 | $18K | 4/29/2025 | View on chart |
| MDT | ▲ Buy | Grant | 2,083 | $175K | 4/28/2025 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 192 | $16K | 5/1/2024 | View on chart |
| MDT | ▲ Buy | Grant | 2,165 | $175K | 4/29/2024 | View on chart |
| GILD | ▲ Buy | Grant | 1,887 | $0 | 5/3/2023 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 169 | $15K | 5/2/2023 | View on chart |
| GILD | ▼ Sell | Gift | 12,868 | $0 | 5/1/2023 | View on chart |
| MDT | ▲ Buy | Grant | 1,930 | $175K | 5/1/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 8,442 | $442K | 3/9/2023 | View on chart |
| GILD | ▲ Buy | Grant | 2,444 | $0 | 5/5/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 2,223 | — | 5/3/2022 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 161 | $17K | 5/3/2022 | View on chart |
| MDT | ▲ Buy | Grant | 1,697 | $0 | 5/2/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 16,322 | $418K | 4/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MiniMed completes separation from Medtronic
Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.
MiniMed completes separation from Medtronic. Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.